Omaha doctors at Nebraska Medicine are testing a new device for delivering chemotherapy directly into pancreatic tumors. A method that might improve quality of life and lifespan for patients.
RELATED | New pancreatic cancer drug that doubles survival time now available at Nebraska Medicine
WATCH KATRINA’S STORY BELOW
Nebraska Medicine trials catheter targeting pancreatic tumors
The catheter, still in the trial stage, targets the tumor rather than sending chemotherapy throughout the entire body — an approach that medical oncologist Dr. Kelsey Klute says is easy for patients to understand…